focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ten year exclusive distribution agreement

24 May 2011 07:00

RNS Number : 1215H
Omega Diagnostics Group PLC
24 May 2011
 



 

Omega Diagnostics Group PLC

("Omega" or "the Company")

 

Ten year exclusive distribution agreement ("Agreement")

 

Omega, the AIM listed medical diagnostics company, announces that its subsidiary, Cambridge Nutritional Sciences Limited, (CNS) has signed a ten year exclusive distribution agreement with Toyota Tsusho America Inc., (TAI) covering the future sale and distribution of its Food Detective™ product into the US market.

 

Prior to being able to sell Food Detective™ in the US market, the product will first need to undergo a regulatory approval process with the US Food and Drug Administration ("US FDA"). Under the terms of the Agreement, TAI will fund the costs involved in obtaining relevant clinical data and information needed for an intended submission under the US FDA 510(k) clearance procedure which is expected to take 1-2 years.

 

Andrew Shepherd, CEO of Omega, said: "We're very pleased to announce this deal with TAI for distribution of Food Detective™ in the US. The product has been sold in over 50 countries and is well accepted as being a reliable test for those people suffering from the effects of food intolerance. This cost effective test has great potential in the significant US market. The US FDA regulatory approval process is likely to take time and significant resources and having a strong partner such as TAI will greatly assist this process."

 

Commenting on the distribution agreement, William Weiner, COO of TAI, said: "Toyota Tsusho America is excited to work with CNS by providing Food Detective™, which may help meet the needs of Americans who suffer from symptoms related to food intolerance. Food Detective™ provides TAI another proprietary diagnostic test to add to its increasing portfolio. Utilising our knowledge and experience in the diagnostic testing market in the US, along with our superior logistics, and supply chain, we look forward to selling the product through a variety of sales channels, after receiving FDA clearance."

 

 

Further enquiries:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Ian Soanes

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Helen Westaway

Mob: 07841 917 679 or helen.westaway@walbrookpr.com

 

 

Information on TAI:

 

Toyota Tsusho America, Inc. (TAI) is a wholly owned subsidiary of Toyota Tsusho Corporation, which was founded as a trading and supply-chain specialist of the Toyota Group. TAI has been operating in North America since 1961. Over the past four decades, it has evolved from a trader in a limited number of commodities and finished goods to a multi-business enterprise.

 

TAI combines international trading with an expansive range of domestically targeted functions including supply-chain services and intermediate goods processing. Our operating divisions pursue a broad mix of business opportunities related to both industrial and consumer products and services.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUOOVRARAVUAR
Date   Source Headline
6th Sep 20237:00 amRNSAGM Statement
1st Sep 202310:29 amRNSUpdate on proposed Share Reorganisation
31st Aug 20237:00 amRNSProposed Share Reorganisation Timetable
22nd Aug 20237:00 amRNSDirectorate Change
17th Aug 20237:00 amRNSBoard Appointment
15th Aug 20231:45 pmRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSPosting of Annual Report and confirmation of AGM
3rd Aug 20237:00 amRNSFinal Results
27th Jul 20237:00 amRNSNotice of Results
26th Jul 20232:10 pmRNSHolding(s) in Company
6th Jun 202311:19 amRNSHolding(s) in Company
5th Jun 20234:51 pmRNSHolding(s) in Company
2nd Jun 20232:45 pmRNSHolding(s) in Company
22nd May 20235:33 pmRNSHolding(s) in Company
10th May 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th May 20233:42 pmRNSDirector/PDMR Shareholding
21st Apr 20239:48 amRNSHolding(s) in Company
19th Apr 20239:31 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update
22nd Mar 20235:57 pmRNSBlock Listing Six Monthly Return
22nd Mar 20233:00 pmRNSHolding(s) in Company
6th Mar 20232:31 pmRNSHolding(s) in Company
27th Jan 20233:03 pmRNSHolding(s) in Company
27th Jan 20239:36 amRNSDirector/PDMR Shareholding
18th Jan 20237:00 amRNSTrading update
16th Jan 202310:56 amRNSHolding(s) in Company
6th Jan 20237:00 amRNSUS expansion update
3rd Jan 202312:34 pmRNSHolding(s) in Company
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 202212:01 pmRNSHolding(s) in Company
30th Nov 20229:35 amRNSHolding(s) in Company
25th Nov 20227:00 amRNSReceipt of deferred consideration
24th Nov 20227:00 amRNSHalf-year Report
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20222:05 pmRNSSecond Price Monitoring Extn
23rd Nov 20222:00 pmRNSPrice Monitoring Extension
18th Nov 202212:09 pmRNSHolding(s) in Company
16th Nov 20222:06 pmRNSSecond Price Monitoring Extn
16th Nov 20222:00 pmRNSPrice Monitoring Extension
15th Nov 20227:00 amRNSConfirmation of Results and Investor Presentation
14th Nov 20227:00 amRNSPartnership agreement with Software Provider
8th Nov 20229:04 amRNSLaunch of new all-employee share incentive plan
26th Oct 20222:50 pmRNSResult of AGM
26th Oct 20227:00 amRNSAGM Statement and Notice of Results
11th Oct 20227:00 amRNSScientific Director to present at FIDHC
5th Oct 20227:00 amRNSPositive WHO data received for VISITECT® CD4 test
27th Sep 20227:00 amRNSPosting of Annual Report and confirmation of AGM
20th Sep 202212:05 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.